TTIC staff facilitates the creation of start-up companies by working with faculty to identify applications for their technologies, refine the business case, and identify public and private funding to advance their discoveries. We have helped researchers tap into venture networks that provide not only funding potential but also mentoring for first-time inventor founders. The TTIC further catalyzes start-ups by building relationships with sources of private funding (such as angel, seed-stage, and venture investors), by proactively seeking corporate research collaborations, and by supporting selected translational research through the Tufts Launchpad | Accelerator program.
The TTIC also helps investigators tap public programs such as MassBio and MassConnect and funding sources such as the Small Business Innovation Research (SBIR) program of the federal government. To encourage a culture of technology transfer and entrepreneurism, the TTIC provides seminars on intellectual property development and start-up company formation.
It takes passion, hard work, and vision to bring academic discoveries to the marketplace. The TTIC is privileged to work with Tufts inventors and their promising new technologies—as well as our licensees—as they transform early-stage discoveries into market-ready products.
Selected Tufts University Start-Ups (1997 to present)
|1997: Paratek Pharmaceuticals – Omadacycline for antibiotic-resistant infections||2015: Visual Classrooms – Interactive learning and collaboration environment|
|1997: Securos – Veterinary orthopedics||2018: Bach Biosciences – Cancer therapies|
|1998: Illumina – Microarray genotyping instruments; 7,000 employees worldwide||2018: Endo Guidance Technologies – Fiber optic-based shape and position tracking for endoscopy|
|2000: Serica (Allergan) – Soft tissue support/repair||2018: Cambridge Crops – Natural, edible solutions for extending freshness of foods|
|2007: Quanterix – Single-molecule arrays for ultrasensitive biomarker detection||2018: Hopewell Therapeutics – Intracellular drug delivery platform|
|2011: iCreate to Educate (HUE) – Stop-action movie animation software||2019: Jersey Biosciences – Flexible guide RNA cloning system for CRISPR/Cas9 applications|
|2011: Hemera Biosciences – Gene therapy for treatment of age-related macular degeneration||2019: Dynocardia – Wearable blood pressure monitoring device|
|2012: GliaCure – Therapies for neuro-cognitive disorders, Alzheimer’s disease||2019: PhagePro – Fast onset, oral therapeutic for prevention of cholera|
|2012: Vaxess Technologies – Silk-based therapeutic and diagnostic reagent stabilization and microneedle delivery||2019: ZwitterCo – Cost-effective treatment of challenging wastewater|
|2013: Kinderlab Robotics – Childhood software/hardware programming kit||2019: Visiogene – Cell-penetrating peptides for delivery of ocular therapeutics|
|2014: Sofregen Medical – Silk-based tissue/dermal fillers||2019: Adecto Pharmaceuticals – Targeted therapies for aggressive ADAM8-positive cancers|